Evaluation of ERAS protocol in outpatient anorectal surgeries

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201113049373N4

Enrollment

Registered

2022-02-24

Start date

2022-02-24

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorectal disease. Anorectal fistula

Interventions

Intervention 1: Intervention group: they receive acetaminophen 1 gr and gabapentin 300 mg before surgery, the anesthesia is like control group. Then, they receive acetaminophen (1000 mg TDS) and gabap

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with age (18-70) years that agree the letter of satisfaction. ASA I to III All patients that underwent fistula surgery with pathway greater than 1 cm, internal or external hemorrhoidectomy, hemorrhoidopexia, elective fissure sphicterectomy

Exclusion criteria

Exclusion criteria: Age less than 18 or greater than 70 years Emergency surgery Patients with kidney, liver failure or transplantation Pregnant patients Unsatisfactory Used opioid or opioid antagonist Patients that underwent minor surgery, such as resection of a pach of external hemorrhoid, fistula tract less than 1 cm or peri anal abscess drainage.

Design outcomes

Primary

Measure	Time frame
Evaluation of ERAS protocol in outpatient anorectal surgeries compared to traditional method and impact of quality of life. Timepoint: Dad and 1400 to More as 1401. Method of measurement: Questionnaire of Post Anesthetic Discharge Scoring System) - visual analoge score & functional pain score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsan Rahimpour

Tehran University of Medical Sciences

Erahimpour@sina.tums.ac.ir+98 21 6321 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026